Mohammed Alahmari
Overview
Explore the profile of Mohammed Alahmari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alghamdi A, Alahmari M, Aljohani K, Alanazi A, Al Ibrahim B, Alshowair M, et al.
Saudi J Gastroenterol
. 2025 Jan;
31(2):82-92.
PMID: 39849820
Background: The emergence of tumor necrosis factor inhibitors (anti-TNF) has considerably changed the management of inflammatory bowel disease (IBD) in patients who do not respond to traditional therapies. This study...
2.
Mamani U, Ibrahim M, Liu Y, Fetse J, Lin C, Kandel S, et al.
Pharm Res
. 2024 Dec;
41(12):2275-2288.
PMID: 39681781
Purpose: The PD-1/PD-L1 pathway is one of the most effective immune checkpoint pathways utilized for cancer immunotherapy. Despite the success of anti-PD-1/PD-L1 mAbs, there is growing interest in developing low...
3.
Sreedharan J, Alharbi A, Alsomali A, Gopalakrishnan G, Almojaibel A, Alajmi R, et al.
Front Artif Intell
. 2024 Sep;
7:1451963.
PMID: 39290718
Background: Artificial intelligence (AI) is reforming healthcare, particularly in respiratory medicine and critical care, by utilizing big and synthetic data to improve diagnostic accuracy and therapeutic benefits. This survey aimed...
4.
Shaji S, Patel P, Mamani U, Guo Y, Koirala S, Lin C, et al.
Int J Nanomedicine
. 2024 Sep;
19:8769-8778.
PMID: 39220196
Introduction: The tumor microenvironment (TME) of pancreatic cancer is highly immunosuppressive and characterized by a large number of cancer-associated fibroblasts, myeloid-derived suppressor cells, and regulatory T cells. Stimulator of interferon...
5.
Alotaibi A, Alhubayshi A, Allehibi A, Almtawa A, Alotaibi N, Alghamdi A, et al.
Saudi J Med Med Sci
. 2024 May;
12(2):169-174.
PMID: 38764558
Background: Patients with inflammatory bowel disease (IBD) may also experience extraintestinal manifestations (EIMs), which can affect various organ systems, and their occurrence is based on disease activity. Objectives: To determine...
6.
Mustafa B, Fetse J, Kandel S, Lin C, Adhikary P, Mamani U, et al.
Adv Ther (Weinh)
. 2024 Apr;
6(12).
PMID: 38655206
Cancer immunotherapy targeting adaptive immune cells has been attracting considerable interest due to its great success in treating multiple cancers. Recently, there is also increasing interest in agents that can...
7.
Sreedharan J, Karthika M, Alqahtani A, Albalawi I, Alenazi M, Alanazi A, et al.
Heliyon
. 2024 Apr;
10(8):e29434.
PMID: 38644873
Background: Over the past ten years, significant transformations have occurred in the healthcare landscape, presenting respiratory therapists (RTs) with a mix of challenges and opportunities. Hence, their perceptions about career...
8.
Sreedharan J, Subbarayalu A, Kamalasanan A, Albalawi I, Krishna G, AlAhmari A, et al.
Clinicoecon Outcomes Res
. 2024 Apr;
16:173-185.
PMID: 38562567
Background: Performance evaluation in the allied healthcare education sector is complex, making it essential for policymakers and managers to approach it comprehensively and thoughtfully to understand their performance. Hence, the...
9.
Alahmari A, Krishna G, Jose A, Qoutah R, Hejazi A, Abumossabeh H, et al.
PeerJ
. 2023 Dec;
11:e16694.
PMID: 38144193
Background: Few studies have looked at how SARS-CoV-2 affects pulmonary function, exercise capacity, and health-related quality of life over time. The purpose of this study was to evaluate these characteristics...
10.
Alotaibi Y, Allehibi A, Almtawa A, Alotaibi N, Alghamdi A, Alrajhi S, et al.
Saudi J Med Med Sci
. 2023 Nov;
11(4):305-313.
PMID: 37970458
Background: Patients with inflammatory bowel disease (IBD) are at a higher risk of cytomegalovirus (CMV) colitis because of their immunocompromised status. There are no studies from Saudi Arabia regarding the...